Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Missouri
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Missouri
5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Missouri.
Cities in Missouri
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Kansas City Veterans Affairs Medical Center, Kansas City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- The Curators of the University of Missouri on behalf of University of Missouri Health Care, Columbia
- The Washington University, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT07478172A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- The Washington University, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.